Our preliminary results revealed that IRF-2 was up-regulated in CRC tissues, which was significantly correlated with distant metastasis and preoperative serum CEA level, as well as a poor overall survival in patients with CRC based on our study cohort. The gene discussed is CEACAM5; the disease is colorectal carcinoma.